New Member to the CCRA Board
CCRA welcomes Dr. Dajan O’Donnell to its Board as the representative for the Cancer Research Society, where he serves as the Director of Scientific Affairs and Partnerships. Dajan is a seasoned professional with recent experience at Exactis Innovation and a long tenure in the pharmaceutical industry. He has a PhD in neurology and neurosurgery.
New Leadership at TFRI
Effective August 1st, 2021, Dr. Jim Woodgett, PhD, FRSC, a senior scientist based at the Lunenfeld-Tanenbaum Research Institute (LTRI) at Sinai Health will become the new President and Scientific Director of The Terry Fox Research Institut... Read More »
Effective August 1st, 2021, Dr. Jim Woodgett, PhD, FRSC, a senior scientist based at the Lunenfeld-Tanenbaum Research Institute (LTRI) at Sinai Health will become the new President and Scientific Director of The Terry Fox Research Institut... Read More »
2018 Investment in Cancer Research: Report Released
Today, CCRA released its latest report on the investment in cancer research. It reveals that $491M was invested in cancer research in 2018. Although a slight increase since 2017 (up $17M), the investment has been fairly constant over the past five years.
This year's report includes some new analyses, which quantify the cancer-related health services ... Read More »
Today, CCRA released its latest report on the investment in cancer research. It reveals that $491M was invested in cancer research in 2018. Although a slight increase since 2017 (up $17M), the investment has been fairly constant over the past five years.
This year's report includes some new analyses, which quantify the cancer-related health services ... Read More »